Promising results for the “PULSAR” and “RACE” clinical trials on sotarcept in pulmonary arterial hypertension

On 20.5.2021 Respifil, the French health network for rare pulonary diseases, published an article by Prof. Marc Humbert and Dr. Xavier Jais reporting on the American Thoracic Society (ATS)’s 2022 Congress and the promising results of the “PULSAR” and “RACE” studies for sotatercept in pulmonary arterial hypertension.

Read more on the Respifil website at this link


Scroll to Top